Try our Advanced Search for more refined results

April 08, 2021

King County et al v. Teva Pharmaceutical Industries Ltd et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 09, 2023

    Teva Wants Out of Case Targeting Blockbuster MS Drug

    Teva Pharmaceuticals Ltd. said Thursday it should be able to escape insurance payor claims alleging an elaborate campaign to suppress generic competition for Teva's multiple sclerosis drug Copaxone, arguing the claims are time-barred and the payors can't sue because they are not direct drug purchasers.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login